Precursor frequency and affinity determine B cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens

RK Abbott, JH Lee, S Menis, P Skog, M Rossi, T Ota… - Immunity, 2018 - cell.com
How precursor frequencies and antigen affinities impact interclonal B cell competition is a
particularly relevant issue for candidate germline-targeting HIV vaccine designs because of …

Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells

JH Lee, L Toy, JT Kos, Y Safonova, WR Schief… - NPJ vaccines, 2021 - nature.com
A successful HIV vaccine eliciting broadly neutralizing antibodies (bnAbs) must overcome
the hurdle of being able to activate naive precursor B cells encoding features within their …

B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models

D Huang, RK Abbott… - Proceedings of the …, 2020 - National Acad Sciences
Animal models of human antigen-specific B cell receptors (BCRs) generally depend on
“inferred germline” sequences, and thus their relationship to authentic naive human B cell …

The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen

C Havenar-Daughton, A Sarkar, DW Kulp… - Science translational …, 2018 - science.org
Traditional vaccine development to prevent some of the worst current pandemic diseases
has been unsuccessful so far. Germline-targeting immunogens have potential to prime …

HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen

JG Jardine, DW Kulp, C Havenar-Daughton, A Sarkar… - Science, 2016 - science.org
Induction of broadly neutralizing antibodies (bnAbs) is a major HIV vaccine goal. Germline-
targeting immunogens aim to initiate bnAb induction by activating bnAb germline precursor …

Anti–HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity

P Dosenovic, EE Kara, AK Pettersson… - Proceedings of the …, 2018 - National Acad Sciences
The discovery that humans can produce potent broadly neutralizing antibodies (bNAbs) to
several different epitopes on the HIV-1 spike has reinvigorated efforts to develop an …

Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen

JG Jardine, T Ota, D Sok, M Pauthner, DW Kulp… - Science, 2015 - science.org
A major goal of HIV-1 vaccine research is the design of immunogens capable of inducing
broadly neutralizing antibodies (bnAbs) that bind to the viral envelope glycoprotein (Env) …

Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates

JM Steichen, I Phung, E Salcedo, G Ozorowski… - Science, 2024 - science.org
Germline-targeting immunogens hold promise for initiating the induction of broadly
neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen …

Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

KO Saunders, K Wiehe, M Tian, P Acharya, T Bradley… - Science, 2019 - science.org
INTRODUCTION A major goal of HIV-1 vaccine development is the design of immunogens
that induce broadly neutralizing antibodies (bnAbs). However, vaccination of humans has …

A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses

JM Steichen, YC Lin, C Havenar-Daughton, S Pecetta… - Science, 2019 - science.org
INTRODUCTION HIV newly infects 1.8 million people each year, making development of an
HIV vaccine a global health priority. Nearly all licensed vaccines protect by inducing …